摘要: Expanded genetic carrier testing is changing clinical practice. Current experience highlights the need for rigorous curation of tens thousands variants as to their pathogenicity and phenotypic effects. There an urgent strategies present a range options families enable them make informed decisions. The potential exists avoid great majority serious inherited, but not de novo, single-gene disabilities.